Klotho Therapeutics' Series A Round

Klotho Therapeutics raised a round of funding on November 02, 2017. Investors include Thynk Capital.

Klotho Therapeutics is a biotechnology company developing a patent-pending Klotho protein that has potential to delay diseases of aging and help people live well longer. Naturally occurring in humans …

Articles about Klotho Therapeutics' Series A Round: